These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25624512)

  • 1. Diamond: shedding light on structure-based drug discovery.
    Brown DG; Shotton EJ
    Philos Trans A Math Phys Eng Sci; 2015 Mar; 373(2036):. PubMed ID: 25624512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The conformational musings of a medicinal chemist.
    Finch H
    Drug Discov Today; 2014 Mar; 19(3):320-5. PubMed ID: 24184532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using X-ray crystallography in drug discovery.
    Rowland RS
    Curr Opin Drug Discov Devel; 2002 Jul; 5(4):613-9. PubMed ID: 12197319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automation of X-ray crystallography.
    Abola E; Kuhn P; Earnest T; Stevens RC
    Nat Struct Biol; 2000 Nov; 7 Suppl():973-7. PubMed ID: 11104004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent progress in robot-based systems for crystallography and their contribution to drug discovery.
    Ferrer JL; Larive NA; Bowler MW; Nurizzo D
    Expert Opin Drug Discov; 2013 Jul; 8(7):835-47. PubMed ID: 23656378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput protein crystallography and drug discovery.
    Tickle I; Sharff A; Vinkovic M; Yon J; Jhoti H
    Chem Soc Rev; 2004 Oct; 33(8):558-65. PubMed ID: 15480479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective.
    Rester U
    Curr Opin Drug Discov Devel; 2008 Jul; 11(4):559-68. PubMed ID: 18600572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid-access, high-throughput synchrotron crystallography for drug discovery.
    Wasserman SR; Koss JW; Sojitra ST; Morisco LL; Burley SK
    Trends Pharmacol Sci; 2012 May; 33(5):261-7. PubMed ID: 22521107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Software for rapid prototyping in the pharmaceutical and biotechnology industries.
    Kappler MA
    Curr Opin Drug Discov Devel; 2008 May; 11(3):389-92. PubMed ID: 18428093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design.
    Cook BN; Bentzien J; White A; Nemoto PA; Wang J; Man CC; Soleymanzadeh F; Khine HH; Kashem MA; Kugler SZ; Wolak JP; Roth GP; De Lombaert S; Pullen SS; Takahashi H
    Bioorg Med Chem Lett; 2009 Feb; 19(3):773-7. PubMed ID: 19111460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential of synchrotron X-ray powder diffractometry for detection and quantification of small amounts of crystalline drug substances in pharmaceutical tablets.
    Yamada H; Masuda K; Ishige T; Fujii K; Uekusa H; Miura K; Yonemochi E; Terada K
    J Pharm Biomed Anal; 2011 Sep; 56(2):448-53. PubMed ID: 21703798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. X-ray crystallography of chemical compounds.
    Deschamps JR
    Life Sci; 2010 Apr; 86(15-16):585-9. PubMed ID: 19303027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of the X-ray structure of the beta2-adrenergic receptor for drug discovery. Part 2: Identification of active compounds.
    Sabio M; Jones K; Topiol S
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5391-5. PubMed ID: 18829308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Itk kinase inhibitors: initial efforts to improve the metabolical stability and the cell activity of the benzimidazole lead.
    Moriarty KJ; Winters M; Qiao L; Ryan D; DesJarlis R; Robinson D; Cook BN; Kashem MA; Kaplita PV; Liu LH; Farrell TM; Khine HH; King J; Pullen SS; Roth GP; Magolda R; Takahashi H
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5537-40. PubMed ID: 18819794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, SAR, and X-ray structure of novel biaryl-based dipeptidyl peptidase IV inhibitors.
    Qiao L; Baumann CA; Crysler CS; Ninan NS; Abad MC; Spurlino JC; Desjarlais RL; Kervinen J; Neeper MP; Bayoumy SS; Williams R; Deckman IC; Dasgupta M; Reed RL; Huebert ND; Tomczuk BE; Moriarty KJ
    Bioorg Med Chem Lett; 2006 Jan; 16(1):123-8. PubMed ID: 16236500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of an Aurora kinase inhibitor through site-specific dynamic combinatorial chemistry.
    Cancilla MT; He MM; Viswanathan N; Simmons RL; Taylor M; Fung AD; Cao K; Erlanson DA
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3978-81. PubMed ID: 18579375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of new binding elements in DPP-4 inhibition and their applications in novel DPP-4 inhibitor design.
    Liang GB; Qian X; Biftu T; Singh S; Gao YD; Scapin G; Patel S; Leiting B; Patel R; Wu J; Zhang X; Thornberry NA; Weber AE
    Bioorg Med Chem Lett; 2008 Jul; 18(13):3706-10. PubMed ID: 18524582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput X-ray crystallography for drug discovery.
    Blundell TL; Patel S
    Curr Opin Pharmacol; 2004 Oct; 4(5):490-6. PubMed ID: 15351354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New light for science: synchrotron radiation in structural medicine.
    Sorensen TL; McAuley KE; Flaig R; Duke EM
    Trends Biotechnol; 2006 Nov; 24(11):500-8. PubMed ID: 17005277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of new Gram-negative antivirulence drugs: structure and properties of novel E. coli WaaC inhibitors.
    Moreau F; Desroy N; Genevard JM; Vongsouthi V; Gerusz V; Le Fralliec G; Oliveira C; Floquet S; Denis A; Escaich S; Wolf K; Busemann M; Aschenbrenner A
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4022-6. PubMed ID: 18571407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.